DNA sequencing: Changing the landscape of science and biology

March 26, 2013 by Lisa Catanese
Brenton Graveley, professor of genetics and developmental biology. Credit: Lanny Nagler for UConn Health Center

UConn researchers are at the forefront of new discoveries and understanding about the smallest molecules in the body that can have a momentous impact on human health.

Brenton Graveley, professor of genetics and at UConn Health Center and UConn's Institute for System Genomics, and coauthor of a recent review article in Molecular Cell with fellow UConn postdoctoral researcher Alex Plocik, explains how government-funded research consortia are using advances in DNA sequencing technology to unlock the mysteries surrounding diseases and disorders. By sharing this DNA sequence information with other researchers, can be made even faster. Graveley is a lead investigator in one such government-funded , the ENCODE project.

Sequencing involves mapping out the order of molecules within DNA, which is the blueprint or building blocks of life because it contains all of the needed to build and maintain an organism. "DNA sequencing has changed the whole landscape of science and biology," Graveley says. "It's exploding exponentially, and there's no end in sight."

Understanding each individual's DNA sequence allows doctors to develop treatments and cures specifically targeted to that person's needs. "That's the promise of personalized medicine," he explains. "People may come in with totally unknown symptoms, and by sequencing their DNA we could use this information to treat them on an individual basis."

Today's computer technology has made interpreting possible. In 2003, the complete human genome was sequenced through the U.S. government's , taking 13 years and costing about $3 billion. The project identified all of the more than 20,000 genes in and determined the sequences of the three billion chemical that comprise it.

Health Center researchers are at the forefront of new discoveries about the smallest molecules that have a major impact on human health. Credit: Shutterstock Photo

Today, this same sequencing can be done by a stand-alone laboratory in one day for several thousand dollars. "This research provides an opportunity for doctors to do testing on people with a certain disorder to study the genes which, when mutated, caused that disease," he says. "It's a game-changer."

The 1997 sci-fi film Gattaca imagined a world where people put their finger on a sensor and their entire DNA was analyzed on the spot. "The technology is in development right now to allow that to happen," Graveley explains. "The science fiction that was dreamed up in a movie is essentially coming to be."

Earlier this year, the University of Connecticut and the State of Connecticut introduced Next Generation Connecticut, a plan to expand research, education and innovation in the science, technology, engineering and math (STEM) studies at UConn. Designed to put UConn at the forefront of technology and research, the program is expected to benefit the entire state by creating new jobs, innovations and start-up companies.

"There is a large consortium of researchers who are generating rich data – so rich that we can't analyze all aspects of it," Graveley says. "What this means is that researchers can download and analyze data to make new discoveries about how biology works, without having to do any experiments. One of the goals of Next Generation Connecticut is to create these jobs and train people to have the knowledge to analyze data in ways that haven't been done before."

UConn researchers are joining forces with genomics medicine experts at Jackson Laboratory, which is building a $1.1 billion research facility on the Health Center's Farmington campus, to make further discoveries in the area of human genomics and to advance the computational tools for interpreting the data coming from this type of research. To accelerate research in this interdisciplinary field, UConn has brought together nine of its schools/colleges and the Jackson Laboratory to create the Institute for Systems Genomics.

Graveley and Plocik teamed with other experts on a second review article recently published in the journal Cell that covers a related topic involving techniques to splice RNA, which acts as a messenger to carry out instructions from DNA. It serves as another example of the wealth of genetics research and expertise at UConn.

DNA sequencing can't be done for every person quite yet, because the process is still expensive and because doctors need to be trained on how to use the information that sequencing provides, since the science is new to them, too. And there is still a large amount of information in DNA that researchers still don't understand. But this is rapidly changing.

"Sequencing technology will eventually apply to everyone," Graveley says. "Somewhere down the road, maybe in 10 years or even longer, every person born will have their sequenced and have it be a permanent part of their medical record. This information can be used to figure out what's wrong if they become sick and how they can be treated. This is an exciting time."

Related Stories

Recommended for you

A rogue gene is causing seizures in babies—here's how scientists wants to stop it

July 26, 2017
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for answers and better treatment options.

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.